The urgent need for HIV and hepatitis prevention in drug treatment programs in Hungary

AIDS Education and Prevention

Volumn 16, Issue 3, 2004, Pages 276-287

  Gyarmathy, V Anna ^a   Rácz, József ^b   Neaigus, Alan ^c   Ujhelyi, Eszter ^d  

^a NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c Columbia University ^*  (United States)

^d Szent Laszlo Hospital   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COUNSELING; DRUG ABUSE; DRUG USE; HEALTH PROGRAM; HEPATITIS; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUNGARY;

COUNSELING; HEALTH SERVICES RESEARCH; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; HUNGARY; PREVENTIVE HEALTH SERVICES; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS;

EID: 3042601239     PISSN: 08999546     EISSN: None     Source Type: Journal    
DOI: 10.1521/aeap.16.3.276.35435     Document Type: Article

References (29)

1. Centers for Disease Control and Prevention (1993). Technical guidance on HIV counseling. Morbidity and Mortality Weekly Report, 42(RR-2), 11-17.
2. D'Aunno, T., Vaughn, T. E., & McElroy, P. (1999). An institutional analysis of HIV prevention efforts by the nation's outpatient drug abuse treatment units. Journal of Health and Social Behavior, 40(2), 175-192.
3. Des Jarlais, D. C., Stimson, G. V., Hagan, H., & Friedman, S. R. (1996). Injection drug use and emerging blood-borne diseases. Journal of the American Medical Association, 276(13), 1034.
4. Drugs used for treatment of narcotic addicts. (1998). Code of Federal Regulations, title 21, sec. 291.505.
5. Elekes, Z., & Paksi, B. (1999a). Fiatalok Szenvedélyei?! Alkohol- És Drogfogyasztás Valamint Dohányzás a Budapesti Középiskolások Körében" Századvég, 53-73.
6. Elekes, Z., & Paksi, B. (1999b). Technical Report Középiskolások Droghasználata És Alkoholfogyasztása Pest Megyében. ANTSZ Pest Megyei Intézete.
7. Elekes, Z., & Paksi, B. (2001). A Felnõtt Népessé g Droghasználata És Alkoholfogyasztása Magyarorszá gon. Unpublished manuscript, Budapest, Hungary.
8. European Monitoring Centre for Drugs and Drug Addiction. (2002). Annual report on the state of the drugs problem in the European Union and Norway 2002-Supplement. Luxembourg: Office for Official Publications of the European Communities.
9. Gyarmathy, V. A., McNutt, L. A., Molnar, A., Morse, D. L., DeHovitz, J., Ujhelyi, E., & Szamado, S. (2002). Evaluation of a comprehensive AIDS education curriculum in Hungary-The role of good educators. Journal of Adolescence, 25, 495-508.
10. Gyarmathy, V. A., Thomas, R. P., Mikl, J., McNutt, L. A., Morse, D. L., DeHovitz, et al. (2002). Sexual activity and condom use among Eastern European adolescents-The study of Hungarian adolescent risk behaviours. International Journal of STD AIDS, 13(6), 399-405.
11. Hartel, D. M., & Schoenbaum, E. E. (1998). Methadone treatment protects against HIV infection: Two decades of experience in the Bronx, New York City. Public Health Report, 113, (Suppl. 1), 107-115.
12. Kó, J. (2001). A Kábítószerhelyzet Bûnügyi Vetülete. In Á Topolánszky (Ed.), Jelentés a Magyarországi Kábító szerhelyzetõl (pp. 50-62). Budapest, Hungary: Ifjúsági és Sportminisztérium.
13. Levin, S. M., Trumble, J. G., Edmunds, M., Statman, J. M., & Petersen, R. C. (1993). perspectives on linkage of primary health care and substance abuse treatment. Journal of Addictive Diseases, 12(2), 1-8.
14. Longshore, D., Hsieh, S., Danila, B., & Anglin, M. D. (1993). Methadone maintenance and needle/syringe sharing. International Journal of Addiction, 28(10), 983-996.
15. Magura, S., Rosenblum, A., & Rodriguez, E. M. (1998). Changes in HIV risk behaviors among cocaine-using methadone patients. Journal of Addictive Diseases, 17(4), 71-90.
16. McCusker, J., G., Willis, Vickers-Lahti, M., & Lewis, B. (1998). Readmissions to drug abuse treatment and HIV risk behavior. American Journal of Drug and Alcohol Abuse, 24(4), 523-540.
17. Metzger, D. S., Navaline, H., & Woody, G. E. (1998). "Drug abuse treatment as AIDS prevention." Public Health Report, 113(Suppl. 1), 97-106.
18. Moss, A. R., Vranizan, K., Gorter, R., Bacchetti, P., Watters, J., & Osmond, D. (1994). HIV seroconversion in intravenous drug users in San Francisco, 1985-1990. AIDS, 8(2), 223-231.
19. Neaigus, A. (1998). The network approach and interventions to prevent hiv among injection drug users. Public Health Reports, 113(Suppl. 1), 140-150.
20. Pszichiátriai Szakmai Kollégium. (1997). A Drogambulanciák Szakmai Minimum-feltételei. Budapest, Hungary: Author.
21. Pszichiátriai Szakmai Kollégium. (1998). A Drogterápiás Intézetek Szakmai Minimumfeltételei. Budapest, Hungary: Author.
22. Rácz, J., Gyarmathy, V. A., Neaigus, A., & Ujhelyi, E. (in press). HIV infection, risk perception, and syringe sharing among injecting drug users in Hungary.
23. Rhoades, H. M., Creson, D., Elk, R., Schmitz, J., & Grabowski, J. (1998). Retention, HIV risk, and illicit drug use during treatment: Methadone dose and visit frequency. American Journal of Public Health, 88(1), 34-39.
24. Riess, T. H., Kim, C., & Downing, M. (2001). Motives for HIV testing among drug users: An analysis of gender differences. AIDS Education and Prevention, 13(6), 509-523.
25. Spielberg, F., Kurth, A., Gorbach, P. M., & Goldbaum, G. (2001). Moving from apprehension to action: HIV counseling and testing preferences in three at-risk populations. AIDS Education Prevention, 13(6), 524-540.
26. Stark, K., Muller, R., Bienzle, U., & Guggenmoos-Holzmann, I. (1996). Methadone maintenance treatment and HIV risk-taking behaviour among injecting drug users in Berlin. Journal of Epidemiology and Community Health, 50(5), 534-537.
27. Strauss, S. M., Des Jarlais, D. C., Astone, J., & Vassilev, Z. P. 2003. On-site HIV testing in residential drug treatment units: Results of a nationwide survey. Public Health Reports, 118(1), 37-43.
28. Topolánszky, A., (Ed). (2001). Jelentés a Magyarországi Kábítószerhelyzetrol. Budapest, Hungary: GYISM.
29. UNAIDS/World Health Organization. (2000). Hungary.